Ligand validation:5XSA

8EL: 2-[3-[(4-azanyl-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-2H-1,3-thiazol-5-yl]ethyl phosphono hydrogen phosphate

8EL is a Ligand Of Interest in 5XSA designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5XSA_8EL_A_702	92%	28%	0.075	0.965	1.33	1.56	4	9	0	0	100%	0.79
5XSB_8EL_A_702	98%	30%	0.062	0.985	1.45	1.36	5	6	0	0	100%	0.86
5XU2_8EL_A_706	70%	20%	0.126	0.942	1.46	1.9	5	10	4	0	100%	0.4
6YAK_8EL_AAA_301	100%	53%	0.047	0.99	1.07	0.74	2	-	0	0	100%	1
8CI0_8EL_CCC_1002	98%	45%	0.061	0.983	1.24	0.9	1	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.